ASP Isotopes Inc. (ASPI)
NASDAQ: ASPI · IEX Real-Time Price · USD
3.440
+0.060 (1.78%)
At close: Apr 26, 2024, 4:00 PM
3.430
-0.010 (-0.29%)
After-hours: Apr 26, 2024, 5:34 PM EDT
Company Description
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes.
It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28.
The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
ASP Isotopes Inc.
| Country | United States |
| Founded | 2021 |
| IPO Date | Nov 10, 2022 |
| Industry | Chemicals |
| Sector | Materials |
| Employees | 76 |
| CEO | Paul Elliot Mann |
Contact Details
Address: 1101 Pennsylvania Avenue Nw, Suite 300 Washington, District of Columbia 20004 United States | |
| Phone | 202-756-2245 |
Stock Details
| Ticker Symbol | ASPI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001921865 |
| ISIN Number | US00218A1051 |
| Employer ID | 87-2618235 |
| SIC Code | 2890 |
Key Executives
| Name | Position |
|---|---|
| Paul Elliot Mann | President, Chief Executive Officer and Executive Chairman |
| Robert Ainscow | Chief Financial Officer and Chief Operating Officer |
| Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. | Chief Technology Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 10, 2024 | 10-K | Annual Report |
| Apr 9, 2024 | 8-K | Current Report |
| Mar 29, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Feb 29, 2024 | 8-K | Current Report |
| Jan 18, 2024 | 8-K | Current Report |
| Dec 5, 2023 | 8-K | Current Report |
| Nov 30, 2023 | 424B3 | Prospectus |
| Nov 28, 2023 | EFFECT | Notice of Effectiveness |
| Nov 27, 2023 | 8-K | Current Report |
| Nov 21, 2023 | S-1 | General form for registration of securities under the Securities Act of 1933 |